ROYAL BANK OF CANADA - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 187 filers reported holding FIBROGEN INC in Q3 2017. The put-call ratio across all filers is 3.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$13,000
-87.9%
15,265
-61.2%
0.00%
Q2 2023$107,000
-9.3%
39,386
+526.8%
0.00%
Q1 2023$118,000
-64.7%
6,284
-69.8%
0.00%
Q4 2022$334,000
+1013.3%
20,813
+799.4%
0.00%
Q3 2022$30,000
+76.5%
2,314
+45.3%
0.00%
Q2 2022$17,000
-78.8%
1,593
-75.9%
0.00%
Q1 2022$80,000
-58.3%
6,607
-51.4%
0.00%
Q4 2021$192,000
+152.6%
13,593
+82.4%
0.00%
Q3 2021$76,000
-53.7%
7,451
+20.6%
0.00%
Q2 2021$164,000
-79.7%
6,180
-73.4%
0.00%
Q1 2021$807,000
-49.4%
23,233
-45.9%
0.00%
Q4 2020$1,594,000
-46.8%
42,966
-41.1%
0.00%
-100.0%
Q3 2020$2,998,000
+218.9%
72,889
+214.4%
0.00%
Q2 2020$940,000
+14.8%
23,185
-1.5%
0.00%
Q1 2020$819,000
-23.7%
23,530
-6.0%
0.00%
Q4 2019$1,074,000
+22.2%
25,019
+5.3%
0.00%
Q3 2019$879,000
-19.7%
23,758
-1.9%
0.00%
Q2 2019$1,094,000
-25.2%
24,209
-10.0%
0.00%
-100.0%
Q1 2019$1,462,000
+558.6%
26,885
+458.9%
0.00%
Q4 2018$222,000
-48.1%
4,810
-31.7%
0.00%
Q3 2018$428,000
+31.7%
7,039
+35.9%
0.00%
Q2 2018$325,000
+46.4%
5,180
+7.6%
0.00%
Q1 2018$222,000
-17.2%
4,815
-15.2%
0.00%
Q4 2017$268,000
-68.0%
5,681
-63.5%
0.00%
Q3 2017$837,000
+86.0%
15,584
+11.7%
0.00%
Q2 2017$450,000
-24.2%
13,953
-42.0%
0.00%
Q1 2017$594,000
+166.4%
24,057
+130.1%
0.00%
Q4 2016$223,000
+46.7%
10,454
+42.2%
0.00%
Q3 2016$152,000
+20.6%
7,350
-3.9%
0.00%
Q2 2016$126,000
-96.2%
7,650
-95.1%
0.00%
-100.0%
Q1 2016$3,355,000
-50.1%
157,573
-28.6%
0.00%
-50.0%
Q4 2015$6,724,000
+4537.2%
220,706
+3244.5%
0.00%
Q3 2015$145,000
-15.2%
6,599
-9.5%
0.00%
Q2 2015$171,000
+200.0%
7,289
+305.8%
0.00%
Q1 2015$57,000
+200.0%
1,796
+156.6%
0.00%
Q4 2014$19,0007000.00%
Other shareholders
FIBROGEN INC shareholders Q3 2017
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders